---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286137335.md"
description: "Enanta Pharma shares are trading lower. The company reported Q2 financial results."
datetime: "2026-05-12T16:43:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286137335.md)
  - [en](https://longbridge.com/en/news/286137335.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286137335.md)
---

# 

Enanta Pharma shares are trading lower. The company reported Q2 financial results.

### Related Stocks

- [ENTA.US](https://longbridge.com/en/quote/ENTA.US.md)

## Related News & Research

- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026 | ENTA Stock News](https://longbridge.com/en/news/285987900.md)
- [What Madrigal Pharmaceuticals (MDGL)'s Wider Q1 Losses and Rezdiffra Revenue Momentum Mean For Shareholders](https://longbridge.com/en/news/286674743.md)
- [Top Executives Quietly Unload a Wave of ANI Pharmaceuticals Shares](https://longbridge.com/en/news/286348551.md)
- [How Strong UGN-103 Phase 3 Durability Data At UroGen Pharma (URGN) Has Changed Its Investment Story](https://longbridge.com/en/news/286658162.md)